The Effect of Acupressure in Non-breastfeeding Mothers After Preterm Cesarean Delivery
NCT ID: NCT04589000
Last Updated: 2020-10-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
64 participants
INTERVENTIONAL
2019-04-12
2020-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Non-Pharmacological Method to Relieve Back Pain
NCT05893355
The Effects of Acupressure on Pain After Cesarean Section
NCT04337801
The Effects of Acupressure Applied to the Primiparous During Episiotomy
NCT06552104
EFFECTS OF AROMATHERAPY MASSAGE ON LACTATION IN NON-BREASTFEEDING MOTHERS WITH PREMATURE NEWBORNS IN NEONATAL INTENSIVE CARE UNIT
NCT05903872
Nonpharmacological Method for Relief of Episiotomy
NCT05649124
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This randomized controlled experimental study will conduct to determine the effect of acupressure on lactation in non-breastfeeding mothers following preterm caesarean delivery.
The sample of the study will comprise of 64 mothers (32 acupressure-experimental and 32 control group), who will randomly select from among the primipara mothers of premature newborns delivered through cesarean section at Dursun Odabaş Medical Center of Van Yüzüncü Yıl University. Before the implementation, the Depression-Anxiety-Stress Scale and the Richard Campbell Sleep Quality Scale will apply. In post-operative three days, 15-minute acupressure will implement in the morning/evening, for acupressure-group mothers and pump milking will apply; control group mothers will only milked in mornings and evenings. Lactation symptoms will evaluate with Visual Analog Scale and acupressure satisfaction with Analog Patient Satisfaction Scale, and milk quantities will record.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
acupressure
Throughout the study, acupressure will be applied to the acupressure group once on the post-op day 0, 2 times on the post-op 1st day, and once on the post-op 2nd day, 4 times in total for 15 minutes.
15 minutes after acupressure application, milk will be expressed for 15 minutes and the amount of milk expressed will be recorded in the milk measurement table.
acupressure
Throughout the study, acupressure will be applied to the acupressure group once on the post-op day 0, 2 times on the post-op 1st day, and once on the post-op 2nd day, 4 times in total for 15 minutes.
15 minutes after acupressure application, milk will be expressed for 15 minutes and the amount of milk expressed will be recorded in the milk measurement table.
control
No accupressure will be applied. Milk will be expressed for a total of 15 minutes, 1 time on the post-op 0th day, 2 times on the post-op 1st day and once on the post-op 2nd day for a total of 15 minutes and will be recorded in the milk measurement table.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupressure
Throughout the study, acupressure will be applied to the acupressure group once on the post-op day 0, 2 times on the post-op 1st day, and once on the post-op 2nd day, 4 times in total for 15 minutes.
15 minutes after acupressure application, milk will be expressed for 15 minutes and the amount of milk expressed will be recorded in the milk measurement table.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Mothers who gave birth by cesarean operation,
* Mothers who gave birth before 37th week of pregnancy,
* Primiparous mothers,
* Mothers whose baby is lying in NICU,
* Mothers who do not have any chronic diseases,
* Mothers who do not use breast milk enhancing drugs, vitamins and supplements,
* Mothers who do not have any anotomic disorder in the breast,
* Mothers who cannot breastfeed,
* Mothers who do not have any injured skin, fracture, swelling or muscle pain, especially in the little finger.
* Mothers without literacy problems, mental disabilities and communication problems,
* Mothers living within the borders of the province of Van,
* Mothers who agree to participate in the study.
Exclusion Criteria
* Mothers who are multiparous,
* Mothers with chronic disease,
* Mothers who have a condition preventing milking,
* Mothers whose language is insufficient in understanding and speaking Turkish,
* Mothers who have breast abscess problems,
* Mothers who have babies with congenital anomalies,
* They are mothers who do not volunteer to participate in the study
18 Years
35 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Esra SARI
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Esra SARI
Research Assistant
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Esra Sarı
Van, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
esra sarı
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Esra SARI
Identifier Type: REGISTRY
Identifier Source: secondary_id
ESARI
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.